| Sep 18 |
Lantheus Holdings (NASDAQ:LNTH) shareholder returns have been fantastic, earning 306% in 3 years
|
| Sep 15 |
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
|
| Sep 5 |
Lantheus Appoints Julie Eastland as New Board Member
|
| Aug 28 |
We Ran A Stock Scan For Earnings Growth And Lantheus Holdings (NASDAQ:LNTH) Passed With Ease
|
| Aug 28 |
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 20 |
Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
|
| Aug 14 |
Insider Sale: Director Gerard Ber Sells 15,500 Shares of Lantheus Holdings Inc (LNTH)
|
| Aug 12 |
Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update)
|
| Aug 8 |
Lantheus Holdings' (NASDAQ:LNTH) Earnings Are Weaker Than They Seem
|
| Aug 1 |
Lantheus Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
